Casi DeYoung

Casi DeYoung

Corporate Officer/Principal at SHATTUCK LABS, INC.

Net worth: 509 951 $ as of 2026-06-29

55 year
Health Technology
Commercial Services
Consumer Services

Profile

Casi DeYoung is currently Chief Business Officer at Shattuck Labs, Inc. since 2019.
Former roles include Operations Director-Oncology at Merck KGaA, Operations Director-Oncology at EMD Pharmaceuticals, Inc. from 2000 to 2005, Consulting Manager at Accenture Ltd., Vice President-Business Development at Reata Pharmaceuticals, Inc. from 2008 to 2013, Vice President-Business Development at ODC Therapy, Inc. from 2005 to 2008, Chief Business Officer at Mirna Therapeutics, Inc. from 2014 to 2017, and Chief Operating Officer & Vice President at ImmuneSensor Therapeutics, Inc. from 2018 to 2019.
Education includes undergraduate studies at Southwestern University and an MBA from McCombs School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-01-24 73,480 ( 0.08% ) 509 951 $ 2026-06-29

Casi DeYoung active positions

CompaniesPositionStart
SHATTUCK LABS, INC. Corporate Officer/Principal 2019-11-30

Former positions of Casi DeYoung

CompaniesPositionEnd
Chief Operating Officer 2019-11-30
Public Communications Contact 2017-05-31
REATA PHARMACEUTICALS, INC. Corporate Officer/Principal 2013-11-30
Corporate Officer/Principal 2008-02-29
Corporate Officer/Principal 2004-12-31
See the detail of Casi DeYoung's experience

Training of Casi DeYoung

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

35

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Commercial Services

Health Technology

Health Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Commercial Services